BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1743305)

  • 1. Preoperative radiotherapy combined with resection of squamous cell carcinoma of the mid-thoracic oesophagus. Does a histopathological malignancy grading system assess actual survival?
    Lewiński T; Morysiński T; Pietrow D; Sikora K
    Eur J Surg Oncol; 1991 Dec; 17(6):571-4. PubMed ID: 1743305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
    Babu M; Mathur M; Gupta SD; Chattopadhyay TK
    Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Morii E; Mori M; Doki Y
    Ann Surg; 2011 Feb; 253(2):279-84. PubMed ID: 21169807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermia combined with chemotherapy and irradiation for the prolongation of the postoperative prognosis in the patients with esophageal carcinoma invading neighbouring structures.
    Nozoe T; Kuwano H; Sadanaga N; Watanabe M; Yasuda M; Sugimachi K
    Int Surg; 1996; 81(1):21-6. PubMed ID: 8803700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term results of esophageal epidermoid cancers in complete remission after preoperative chemo-radiotherapy].
    Triboulet JP; Amrouni H; Guillem P; Vandenhaute B; Lecomte-Houcke M; Adenis A
    Ann Chir; 1998; 52(6):503-8. PubMed ID: 9752498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
    Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
    Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
    Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma.
    Suntharalingam M; Haas ML; Sonett JR; Doyle LA; Hausner PF; Schuetz J; Greenwald B; Krasna MJ
    Cancer J; 2001; 7(6):509-15. PubMed ID: 11769864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
    Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
    Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital.
    Katlic MR; Wilkins EW; Grillo HC
    J Thorac Cardiovasc Surg; 1990 May; 99(5):929-38. PubMed ID: 2329832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of combined therapy in esophageal cancer.
    Apinop C; Puttisak P; Preecha N
    Hepatogastroenterology; 1994 Aug; 41(4):391-3. PubMed ID: 7959579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and histopathological contributing factors influencing the effectiveness of preoperative hyperthermo-chemo-radiotherapy for the patients with esophageal cancer.
    Kitamura M; Sumiyoshi K; Sonoda K; Kitamura K; Tsutsui S; Toh Y; Kuwano H; Sugimachi K
    Hepatogastroenterology; 1997; 44(13):175-80. PubMed ID: 9058140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multidisciplinary treatment of esophageal cancer].
    Kuwano H; Sadanaga N; Watanabe M; Ikebe M; Mori M; Sugimachi K
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1167-72. PubMed ID: 7687421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy.
    Kim MK; Kim SB; Ahn JH; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HY; Shin JH; Cho KJ; Ryu JS; Park SI
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):725-34. PubMed ID: 18164836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
    Wu TT; Chirieac LR; Abraham SC; Krasinskas AM; Wang H; Rashid A; Correa AM; Hofstetter WL; Ajani JA; Swisher SG
    Am J Surg Pathol; 2007 Jan; 31(1):58-64. PubMed ID: 17197919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Split-course concomitant radiochemotherapy plus surgery vs. surgery alone in squamous cell carcinoma of the esophagus. A non-randomized retrospective study of 184 patients].
    Malhaire JP; Lozac'h P; Simon H; Labat JP; Topart P; Lucas B; Metges JP; Lamezec B
    Bull Cancer; 1997 Apr; 84(4):357-67. PubMed ID: 9238158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.